S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
Log in

ACADIA Pharmaceuticals News Headlines (NASDAQ:ACAD)

$42.45
-2.68 (-5.94 %)
(As of 02/24/2020 01:58 PM ET)
Today's Range
$42.08
Now: $42.45
$44.10
50-Day Range
$39.34
MA: $42.90
$46.87
52-Week Range
$21.56
Now: $42.45
$53.70
Volume950,510 shs
Average Volume1.01 million shs
Market Capitalization$6.54 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.82

Headlines

ACADIA Pharmaceuticals (NASDAQ ACAD) News Headlines

Source:
DateHeadline
ACADIA Pharmaceuticals (ACAD) Set to Announce Earnings on WednesdayACADIA Pharmaceuticals (ACAD) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - February 19 at 5:22 AM
Zacks: Analysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Will Post Quarterly Sales of $95.87 MillionZacks: Analysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Will Post Quarterly Sales of $95.87 Million
www.americanbankingnews.com - February 17 at 5:14 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Average Rating of "Buy" from BrokeragesACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 16 at 12:39 PM
 Analysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Will Post Earnings of -$0.37 Per Share Analysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Will Post Earnings of -$0.37 Per Share
www.americanbankingnews.com - February 15 at 10:31 AM
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc.FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against ACADIA Pharmaceuticals Inc.
www.bloomberg.com - February 14 at 8:13 PM
ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major DepressiveACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive
www.bloomberg.com - February 11 at 12:53 AM
Analysts Expect Breakeven For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Analysts Expect Breakeven For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
finance.yahoo.com - February 5 at 8:18 AM
ACADIA Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:ACAD)ACADIA Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:ACAD)
www.americanbankingnews.com - January 31 at 9:54 AM
ACADIA- From Depression to SchizophreniaACADIA- From Depression to Schizophrenia
finance.yahoo.com - January 29 at 3:27 PM
Acadia Pharmaceuticals Larger Than S&P 500 Component Flowserve CorpAcadia Pharmaceuticals Larger Than S&P 500 Component Flowserve Corp
www.nasdaq.com - January 17 at 6:05 PM
ACADIA Pharmaceuticals (ACAD) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowACADIA Pharmaceuticals (ACAD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 15 at 9:42 PM
ACADIA Pharmaceuticals Inc. (ACAD) CEO Presents at 38th Annual J.P. Morgan Healthcare Conference (Transcript)ACADIA Pharmaceuticals Inc. (ACAD) CEO Presents at 38th Annual J.P. Morgan Healthcare Conference (Transcript)
seekingalpha.com - January 14 at 8:20 PM
ACAD February 28th Options Begin TradingACAD February 28th Options Begin Trading
www.nasdaq.com - January 9 at 4:10 PM
ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
finance.yahoo.com - January 7 at 4:41 PM
Best Stocks of the Decade: Acadia’s Drug Development SuccessBest Stocks of the Decade: Acadia’s Drug Development Success
www.thestreet.com - January 5 at 9:08 PM
Pharma stocks topped the list of top performers in 2019Pharma stocks topped the list of top performers in 2019
www.msn.com - December 31 at 8:40 PM
2 Biotech Stocks Poised to Soar in 20202 Biotech Stocks Poised to Soar in 2020
www.fool.com - December 24 at 2:38 PM
Has ACADIA Pharmaceuticals (ACAD) Outpaced Other Medical Stocks This Year?Has ACADIA Pharmaceuticals (ACAD) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - December 23 at 1:25 PM
Can You Imagine How Chuffed ACADIA Pharmaceuticals's (NASDAQ:ACAD) Shareholders Feel About Its 215% Share Price Gain?Can You Imagine How Chuffed ACADIA Pharmaceuticals's (NASDAQ:ACAD) Shareholders Feel About Its 215% Share Price Gain?
finance.yahoo.com - December 22 at 8:06 AM
Goldman likes Amgen and UnitedHealth Group in premarket analyst actionGoldman likes Amgen and UnitedHealth Group in premarket analyst action
seekingalpha.com - December 16 at 9:16 AM
Acadia Pharma gets a new bull - shares up 2%Acadia Pharma gets a new bull - shares up 2%
seekingalpha.com - December 16 at 9:16 AM
The Zacks Analyst Blog Highlights: ACADIA, Compugen, Cue Biopharma, Epizyme and Krystal BiotechThe Zacks Analyst Blog Highlights: ACADIA, Compugen, Cue Biopharma, Epizyme and Krystal Biotech
finance.yahoo.com - December 12 at 12:10 PM
Moonlighting costs University of California as professors fail to share outside incomeMoonlighting costs University of California as professors fail to share outside income
www.latimes.com - December 6 at 1:57 PM
A 60% Tumble for Sage Therapeutics, and Two More Numbers to KnowA 60% Tumble for Sage Therapeutics, and Two More Numbers to Know
finance.yahoo.com - December 6 at 8:56 AM
BRIEF-ACADIA Pharmaceuticals Says Pivotal Phase 3 Harmony Study Showed Pimavanserin Reduced Risk Of Psychotic RelapseBRIEF-ACADIA Pharmaceuticals Says Pivotal Phase 3 Harmony Study Showed Pimavanserin Reduced Risk Of Psychotic Relapse
www.msn.com - December 5 at 11:21 PM
Wild Biotech Day Sparks $7.6 Billion Shuffle for Neurology TrioWild Biotech Day Sparks $7.6 Billion Shuffle for Neurology Trio
finance.yahoo.com - December 5 at 6:18 PM
Wild Moves In Biotech Amid Deluge of Trial DataWild Moves In Biotech Amid Deluge of Trial Data
www.nasdaq.com - December 5 at 1:17 PM
Why Acadia Pharmaceuticals Stock Is on Fire TodayWhy Acadia Pharmaceuticals Stock Is on Fire Today
www.fool.com - December 5 at 1:17 PM
Acadia Pharma up 16% on pimavanserin data in dementia psychosisAcadia Pharma up 16% on pimavanserin data in dementia psychosis
seekingalpha.com - December 5 at 1:17 PM
Biotech Stocks Are Making Wild Moves Amid a Deluge of Trial DataBiotech Stocks Are Making Wild Moves Amid a Deluge of Trial Data
finance.yahoo.com - December 5 at 1:17 PM
Why This Highflying Biotech Stock Zoomed Near A Profit-Taking ZoneWhy This Highflying Biotech Stock Zoomed Near A Profit-Taking Zone
finance.yahoo.com - December 5 at 1:17 PM
ACADIA Pharma up 10% premarket on positive pimavanserin dataACADIA Pharma up 10% premarket on positive pimavanserin data
seekingalpha.com - December 5 at 8:17 AM
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on CTAD Investor Event (Transcript)ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis on CTAD Investor Event (Transcript)
seekingalpha.com - December 5 at 7:14 AM
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of SchizophreniaACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
finance.yahoo.com - November 25 at 7:39 PM
Top Ranked Momentum Stocks to Buy for November 25thTop Ranked Momentum Stocks to Buy for November 25th
finance.yahoo.com - November 25 at 2:36 PM
ACADIA Pharmaceuticals to Host Investor Event and Webcast From Clinical Trials on Alzheimer’s Disease (CTAD) Meeting on December 4, 2019ACADIA Pharmaceuticals to Host Investor Event and Webcast From Clinical Trials on Alzheimer’s Disease (CTAD) Meeting on December 4, 2019
finance.yahoo.com - November 11 at 9:28 AM
Have Insiders Been Selling ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares?Have Insiders Been Selling ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares?
finance.yahoo.com - November 7 at 9:10 AM
ACADIA Pharmaceuticals Appoints Ponni Subbiah, M.D., M.P.H., as Senior Vice President, Global Head of Medical Affairs and Chief Medical OfficerACADIA Pharmaceuticals Appoints Ponni Subbiah, M.D., M.P.H., as Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
finance.yahoo.com - November 4 at 12:48 PM
Is Acadia Pharmaceuticals Stock Now a Buy?Is Acadia Pharmaceuticals Stock Now a Buy?
www.fool.com - October 31 at 1:15 PM
Acadia Pharmaceuticals Delivers Record Q3 Revenue, Fueled by Antipsychotic Drug NuplazidAcadia Pharmaceuticals Delivers Record Q3 Revenue, Fueled by Antipsychotic Drug Nuplazid
www.fool.com - October 31 at 8:14 AM
BRIEF-ACADIA Pharmaceuticals Reports Third Quarter 2019 Financial ResultsBRIEF-ACADIA Pharmaceuticals Reports Third Quarter 2019 Financial Results
www.msn.com - October 30 at 9:35 PM
ACADIA Pharmaceuticals Inc. 2019 Q3 - Results - Earnings Call PresentationACADIA Pharmaceuticals Inc. 2019 Q3 - Results - Earnings Call Presentation
seekingalpha.com - October 30 at 9:35 PM
ACADIA Pharmaceuticals Reports Third Quarter 2019 Financial ResultsACADIA Pharmaceuticals Reports Third Quarter 2019 Financial Results
finance.yahoo.com - October 30 at 4:34 PM
ACADIA Pharmaceuticals Initiates Phase 3 Pivotal Study of Trofinetide in Rett Syndrome, a Rare Neurodevelopmental Congenital CNS DisorderACADIA Pharmaceuticals Initiates Phase 3 Pivotal Study of Trofinetide in Rett Syndrome, a Rare Neurodevelopmental Congenital CNS Disorder
finance.yahoo.com - October 30 at 4:34 PM
ACADIA Pharmaceuticals Inc. ACAD has coverage initiated with a Market Perform rating and $44.00 price targetACADIA Pharmaceuticals Inc. ACAD has coverage initiated with a Market Perform rating and $44.00 price target
www.marketwatch.com - October 25 at 12:52 PM
Acadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseAcadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - October 24 at 1:51 AM
Acadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseAcadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - October 23 at 2:24 PM
ACADIA Pharmaceuticals to Announce Third Quarter 2019 Financial Results on October 30, 2019ACADIA Pharmaceuticals to Announce Third Quarter 2019 Financial Results on October 30, 2019
finance.yahoo.com - October 16 at 9:28 AM
Acadia Sees Strong Results in Dementia TreatmentAcadia Sees Strong Results in Dementia Treatment
finance.yahoo.com - October 8 at 6:50 PM
ACADIA Pharmaceuticals Presents Additional Positive Data from the Phase 2 CLARITY Study with Pimavanserin in Adjunctive Major Depressive Disorder at 2019 Psych CongressACADIA Pharmaceuticals Presents Additional Positive Data from the Phase 2 CLARITY Study with Pimavanserin in Adjunctive Major Depressive Disorder at 2019 Psych Congress
finance.yahoo.com - October 7 at 12:56 PM
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel